menu search

Tiziana life sciences to present ms treatment at ectrims annual congress

Tiziana Life sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "Treatment Of...

October 11, 2023, 9:26 am

Neurocrine's crinecerfont delivered, but the street has been slow to reward the success

Neurocrine Biosciences has reported very positive Phase III results for crinecerfont in adult and pedia...

October 11, 2023, 3:44 am

Synairgen appoints new cfo as incumbent bows out after nearly 20 years

Synairgen PLC (AIM:SNG, OTC:SYGGF) said Joseph Colliver will succeed John Ward as chief financial officer effective November 6. Colliver comes to Sy...

October 11, 2023, 2:47 am

Sellas receives fda orphan drug designation for sls009 for treatment of acute myeloid leukemia

NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — SELLAS Life sciences Group, Inc. (NASDAQ: SLS) (“SELLAS�...

October 10, 2023, 8:15 pm

Why shares of ventyx biosciences are dropping tuesday

Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy candidate is VTX002 to treat moderate-to-severe ul...

October 10, 2023, 12:55 pm

Bioharvest sciences announces health canada license for vinia sales in canada

BioHarvest sciences Inc. (CSE:BHSC, OTC:CNVCF) announced it has received a Canadian product license f...

October 10, 2023, 12:40 pm

10%-yielding hercules capital is a bdc superstar

Hercules Capital is a top-tier business development company with a strong track record and a high yield. The company specializes in financing high-gro...

October 10, 2023, 11:00 am

A bull market is coming: 1 beaten-down growth stock you could regret not buying on the dip

Caribou Biosciences stock could rocket up more than 400%, according to the consensus price target from ...

October 10, 2023, 5:40 am

Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against pacwest, integra, and enviva and encourages investors to contact the firm

NEW YORK, Oct. 09, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ...

October 10, 2023, 1:00 am

Ibn and biomedwire named official media partners for biopharma nexus events in october 2023

LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) — via InvestorWire — InvestorBrandNetwork (“IBN”), a dynamic communications organization, is delig...

October 9, 2023, 1:35 pm

Anavex: the september data

Anavex Life sciences Corp. presented follow-on data from its Alzheimer's disease trial. This data uses ...

October 9, 2023, 11:37 am

Bet on these 4 top-ranked liquid stocks for robust returns

Here are four top-performing liquid stocks, Neurocrine Biosciences (NBIX), GigaCloud Technology (GCT), ...

October 9, 2023, 9:01 am

Exact sciences schedules third quarter 2023 earnings call

MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact sciences Corp. (Nasdaq: EXAS), a leading provider of...

October 9, 2023, 6:00 am

Exact sciences to present late-breaking data from pivotal blue-c study on next-generation cologuard at acg 2023

MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact sciences Corp. (NASDAQ: EXAS), a leading provider o...

October 9, 2023, 5:58 am

Rosen, a top ranked law firm, encourages integra lifesciences holdings corporation investors to secure counsel before important deadline in securities class action – iart

NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra Lif...

October 8, 2023, 11:11 pm

Bmez: healthy 8% yield, big 17% discount, ~8 years to 'maturity'

BlackRock Health sciences Term Trust announced a distribution cut, and this unique CEF now trades at an...

October 8, 2023, 6:00 pm

Which is the better cancer-testing healthcare stock: exact sciences or guardant health?

Exact sciences and Guardant Health have both enjoyed triple-digit revenue growth over the past five yea...

October 8, 2023, 7:30 am

Columbus mckinnon undervalued as near-term capex pressures obscure the long-term growth opportunities

Columbus McKinnon's shares have declined about 10% this year, as companies have pulled back on investments in factory and logistics automation in the ...

October 7, 2023, 11:54 pm

Alpine immune sciences: november 2023 data release could get ball rolling

Preliminary clinical data from the Alpine Immune Sciences, Inc. ongoing phase 3 RUBY-3 study will be presented at the American Society of Nephrology A...

October 6, 2023, 3:31 pm

Why shares of cassava sciences soared this week

A rash of insider buying helped buoy the clinical-stage biotech's stock. Cassava said it had completed the enrollment of a phase 3 trial for an Alzhei...

October 6, 2023, 3:13 pm


Search within

Pages Search Results: